Is a 200 mg dose of trazodone appropriate for treating insomnia?

Trazodone 200 mg for Sleep: Not Recommended as First-Line

Trazodone 200 mg should not be used as first-line therapy for insomnia, and this dose exceeds the typical effective range for sleep disorders. Major clinical guidelines explicitly advise against trazodone for chronic insomnia due to limited efficacy evidence and concerning adverse effects 1, 2.

Why Guidelines Recommend Against Trazodone

The 2019 VA/DoD guidelines found that trazodone (50-150 mg) showed no difference from placebo in sleep efficiency or discontinuation rates 1. While it improved subjective sleep quality, it failed to improve sleep onset latency, total sleep time, or wake after sleep onset. The guideline authors concluded that "the low-quality evidence supporting the efficacy of trazodone was outweighed by its adverse effect profile" 1.

The 2016 American College of Physicians evidence report similarly found insufficient evidence for trazodone in insomnia treatment 2.

The 200 mg Dose Problem

Your proposed 200 mg dose is at the upper end or exceeds the typical effective range for insomnia:

• Research shows 70% of patients achieve effective insomnia control with 50-200 mg, with most responding to lower doses 3
• Studies demonstrating any benefit typically used 50-150 mg 1, 4
• The FDA label does not establish trazodone for insomnia treatment at any dose 5
• Higher doses increase adverse effects without clear additional benefit for sleep 6

Significant Safety Concerns at This Dose

Adverse effects are dose-dependent and concerning at 200 mg:

Priapism Risk

• 12% incidence reported in one veteran population 3—far higher than previously recognized
• Can cause permanent erectile dysfunction if not treated within 4-6 hours 5
• Risk increases with dose

Cardiovascular Effects

• Orthostatic hypotension and syncope 5
• QT prolongation, ventricular tachycardia, and torsades de pointes reported even at doses ≤100 mg 5
• Cardiac arrhythmias including atrial fibrillation, heart block 5

Other Common Adverse Effects

• Somnolence (7.34× higher odds vs placebo) 7
• Blurred vision (17.5× higher odds) 7
• Dizziness, cognitive impairment, falls (especially concerning in elderly) 2
• Hyponatremia, particularly in elderly and those on diuretics 5

Discontinuation Issues

• Patients are 2.3× more likely to discontinue due to adverse effects compared to placebo 8
• Withdrawal syndrome can occur with abrupt cessation 5

What the Evidence Actually Shows

Recent meta-analyses reveal trazodone's limited efficacy:

• Does NOT improve subjective total sleep time (0.73 minutes difference, not significant) 8
• Improves sleep quality scores but with minimal clinical significance 8
• Extends objective sleep time by only 28 minutes on polysomnography 8
• Minimal effect on sleep latency or daytime impairment 8

Recommended Alternatives

First-line treatments with stronger evidence:

1. Cognitive Behavioral Therapy for Insomnia (CBT-I) - most effective long-term treatment
2. Low-dose doxepin (3-6 mg) - FDA-approved for insomnia, better evidence than trazodone 1
3. Nonbenzodiazepine hypnotics (zolpidem, eszopiclone, zaleplon) - demonstrated efficacy in sleep efficiency, onset latency, and total sleep time 1, though FDA warnings about complex sleep behaviors exist

When Trazodone Might Be Considered

If you must use trazodone despite guideline recommendations:

• Start at 25-50 mg, not 200 mg
• Maximum effective dose typically 100-150 mg 4, 6
• Best for sleep maintenance insomnia (not sleep onset) 9
• Consider primarily when insomnia is secondary to depression requiring antidepressant treatment 7
• Give at least 1 hour before bedtime (not immediately at bedtime like hypnotics) 9
• Directly ask about priapism at follow-up - patients may not volunteer this information 3

Critical Monitoring at 200 mg

If a patient is already on 200 mg:

• Screen for orthostatic hypotension (check lying and standing BP)
• Ask specifically about priapism/prolonged erections
• Monitor for QT prolongation if cardiac risk factors present
• Check sodium levels, especially if elderly or on diuretics
• Assess for next-day sedation and fall risk
• Consider dose reduction to 50-100 mg range

The evidence does not support 200 mg trazodone as appropriate insomnia treatment. Lower doses (50-100 mg) have marginal evidence at best, and even these are not recommended as first-line therapy by major guidelines 1, 2, 10.